#TEAMMEDICAGO
Dead / Abandoned — Abandoned — failure to respond (as of 10 Apr 2024)
What this means for you
This application is over — abandoned 27 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97727847
- Mark type
- Stylized text
- Filed
- 21 Dec 2022
- Abandoned
- 27 Mar 2024
- Attorney of record
- Benjamin M. Cantor
Goods and services
- Class 035 — Advertising and business services: Wholesale store services featuring pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies, excluding healthcare plans and healthcare plan management/administration services
- Class 042 — Scientific and technological services: Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; Operation of a company specializing in the development of pharmaceuticals, pharmaceutical ingredients, vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Owner
- Medicago Inc., Québec (Québec), CA
Prosecution history
- 10 Apr 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 10 Apr 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Dec 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Dec 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Sept 2023 — NON-FINAL ACTION E-MAILED
- 26 Sept 2023 — NON-FINAL ACTION WRITTEN
- 21 Sept 2023 — ASSIGNED TO EXAMINER
- 18 Jan 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Dec 2022 — NEW APPLICATION ENTERED